يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
B of A Securities Maintains Buy on Insmed, Raises Price Target to $96
انسميد +0.91%
Insmed Incorporated INSM | 197.01 | +0.91% |
B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:
INSM) with a Buy and raises the price target from $92 to $96.
